CCM
LGND icon

Context Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Context Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
+46,000
New +$10.8M 0.28% 77

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Context Capital Management's LGND Position: Q2 2026 in Review

Context Capital Management opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 46,000 shares worth $14.5M. The stake represents 0.28% of the portfolio and ranks #77 among its holdings.

71 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Context Capital Management held 46,000 shares of Ligand Pharmaceuticals worth $14.5M as of Q2 2026.
  • Ligand Pharmaceuticals was a new Context Capital Management position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.28% of Context Capital Management's portfolio in Q2 2026, its #77 holding.
  • 71 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.